Filing Flows › Madrigal Pharmaceuticals (MDGL) › Free cash flow
Madrigal Pharmaceuticals (MDGL) free cash flow by quarter
Madrigal Pharmaceuticals' free cash flow was $117M in Q3 2026 (third quarter 2026), +511% from Q2 2026. Over the last 3 quarters it ranged from $19.1M (Q2 2026) to $117M (Q3 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $117M | +511% | +48% |
| Q2 2026 | $19.1M | -76% | — |
| Q3 2025 | $79.0M | — | — |
Q3 2026 at a glance
Madrigal Pharmaceuticals, Q3 2026: revenue $431M (+50% year over year), operating margin 13.0%, net earnings $55.4M, operating cash flow $121M. The chart follows the revenue to costs, profit and cash.
Questions
What is Madrigal Pharmaceuticals' free cash flow?
Madrigal Pharmaceuticals' free cash flow was $117M in Q3 2026 (third quarter 2026), +511% from Q2 2026.
How has Madrigal Pharmaceuticals' free cash flow changed?
Over the last 3 quarters it ranged from $19.1M (Q2 2026) to $117M (Q3 2026).
Q3 2026 results → · How Madrigal Pharmaceuticals makes money →